Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C10H15NO.O4S |
| Molecular Weight | 426.527 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | -2 |
SHOW SMILES / InChI
SMILES
[O-]S([O-])(=O)=O.CN(C)CCC1=CC=C(O)C=C1.CN(C)CCC2=CC=C(O)C=C2
InChI
InChIKey=PKCUSEDYJXJFJO-UHFFFAOYSA-L
InChI=1S/2C10H15NO.H2O4S/c2*1-11(2)8-7-9-3-5-10(12)6-4-9;1-5(2,3)4/h2*3-6,12H,7-8H2,1-2H3;(H2,1,2,3,4)/p-2
| Molecular Formula | C10H15NO |
| Molecular Weight | 165.2322 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | H2O4S |
| Molecular Weight | 98.078 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Hordenine is a natural Phenethylamine compound that occurs in a number of different plants, but especially barley grass. It is structurally similar to the amino acid Tyramine. It antagonized D2-mediated beta-arrestin recruitment indicating functional selectivity. Hordenine inhibited melanogenesis by suppressing cAMP production, which is involved in the expression of melanogenesis-related proteins. Hordenine may be an effective inhibitor of hyperpigmentation. Hordenine is an indirectly acting adrenergic drug. It liberates norepinephrine from stores. In isolated organs and those structures with reduced epinephrine contents, the hordenine-effect is only very poor. Experiments in intact animals (rats, dogs) show that hordenine has a positive inotropic effect upon the heart, increases systolic and diastolic blood pressure, peripheral blood flow volume, inhibits gut movements but has no effect upon the psychomotorical behavior of mice. Hordenine is considered to be generally very safe and well-tolerated in healthy adults. Hordenine is a nootropic compound that works equally well for cognitive enhancement and athletic performance.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2993 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2570842 |
|||
Target ID: CHEMBL217 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28281694 |
13.0 µM [Ki] | ||
Target ID: GO:0006171 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23768344 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Role of Mitochondrial Enzymes and Sarcoplasmic ATPase in Cardioprotection Mediated by Aqueous Extract of Desmodium gangeticum (L) DC Root on Ischemic Reperfusion Injury. | 2010-11 |
|
| [Alkaloids from Senecio scandens]. | 2010-10 |
|
| Alkaloids in marine algae. | 2010-02-04 |
|
| Anticancer drugs from marine flora: an overview. | 2010 |
|
| Changes in apolar metabolites during in vitro organogenesis of Pancratium maritimum. | 2009-11-17 |
|
| Antimicrobial evaluation of clerodane diterpenes from Polyalthia longifolia var. pendula. | 2009-03 |
|
| Examination of a pre-exercise, high energy supplement on exercise performance. | 2009-01-06 |
|
| Thermogenic effect of an acute ingestion of a weight loss supplement. | 2009-01-06 |
|
| The acute effects of the thermogenic supplement Meltdown on energy expenditure, fat oxidation, and hemodynamic responses in young, healthy males. | 2008-12-16 |
|
| Certification of standard reference materials containing bitter orange. | 2008-07 |
|
| Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium). | 2007-11-28 |
|
| Biomimetic total synthesis and antimicrobial evaluation of anachelin H. | 2007-10-26 |
|
| Fast high-performance liquid chromatography analysis of phenethylamine alkaloids in Citrus natural products on a pentafluorophenylpropyl stationary phase. | 2007-09-21 |
|
| Determination of bitter orange alkaloids in dietary supplement Standard Reference Materials by liquid chromatography with atmospheric-pressure ionization mass spectrometry. | 2007-09 |
|
| Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium. | 2007-08-17 |
|
| Revised NMR data for incartine: an alkaloid from Galanthus elwesii. | 2007-07-12 |
|
| Determination of synephrine in weight-loss products using high performance liquid chromatography with acidic potassium permanganate chemiluminescence detection. | 2007-06-12 |
|
| Determination of synephrine in bitter orange raw materials, extracts, and dietary supplements by liquid chromatography with ultraviolet detection: single-laboratory validation. | 2007-03-22 |
|
| Efficient and sensitive method for quantitative analysis of alkaloids in hardinggrass (Phalaris aquatica L.). | 2006-12-13 |
|
| Phenylalkylamine alkaloids from Stapelia hirsuta L. | 2006-07-10 |
|
| Alkaloids of Haloxylon salicornicum (Moq.) Bunge ex Boiss. (Chenopodiaceae). | 2005-12 |
|
| Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. | 2003-10 |
|
| Galanthindole: a new indole alkaloid from Galanthus plicatus ssp. byzantinus. | 2003-09 |
|
| Screening and confirmation of drugs in urine: interference of hordenine with the immunoassays and thin layer chromatography methods. | 1992-04 |
Sample Use Guides
In Vivo Use Guide
Sources: https://nootriment.com/hordenine-review/
30 mg taken two or three times a day. The best time to take this is about 30 minutes before exercise.
Route of Administration:
Rectal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2570842
Hordenine at concentrations up to 150 uM produced no measurable contraction but it did affect responses to both noradrenaline and tyramine. 25 uM hordenine potentiated significantly, the tonic responses to submaximal doses of noradrenaline and inhibited those to tyramine.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:16:39 GMT 2025
by
admin
on
Mon Mar 31 19:16:39 GMT 2025
|
| Record UNII |
O6NSW8P8Y8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
O6NSW8P8Y8
Created by
admin on Mon Mar 31 19:16:39 GMT 2025 , Edited by admin on Mon Mar 31 19:16:39 GMT 2025
|
PRIMARY | |||
|
DTXSID201017262
Created by
admin on Mon Mar 31 19:16:39 GMT 2025 , Edited by admin on Mon Mar 31 19:16:39 GMT 2025
|
PRIMARY | |||
|
210-749-7
Created by
admin on Mon Mar 31 19:16:39 GMT 2025 , Edited by admin on Mon Mar 31 19:16:39 GMT 2025
|
PRIMARY | |||
|
148336
Created by
admin on Mon Mar 31 19:16:39 GMT 2025 , Edited by admin on Mon Mar 31 19:16:39 GMT 2025
|
PRIMARY | |||
|
76972130
Created by
admin on Mon Mar 31 19:16:39 GMT 2025 , Edited by admin on Mon Mar 31 19:16:39 GMT 2025
|
PRIMARY | |||
|
SUB14118MIG
Created by
admin on Mon Mar 31 19:16:39 GMT 2025 , Edited by admin on Mon Mar 31 19:16:39 GMT 2025
|
PRIMARY | |||
|
236237
Created by
admin on Mon Mar 31 19:16:39 GMT 2025 , Edited by admin on Mon Mar 31 19:16:39 GMT 2025
|
PRIMARY | RxNorm | ||
|
622-64-0
Created by
admin on Mon Mar 31 19:16:39 GMT 2025 , Edited by admin on Mon Mar 31 19:16:39 GMT 2025
|
PRIMARY | |||
|
100000077591
Created by
admin on Mon Mar 31 19:16:39 GMT 2025 , Edited by admin on Mon Mar 31 19:16:39 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |